scholarly journals Spatial Probabilistic Mapping of Metabolite Ensembles in Mass Spectrometry Imaging

2021 ◽  
Author(s):  
Denis Abu Sammour ◽  
James L. Cairns ◽  
Tobias Boskamp ◽  
Carina Ramallo Guevara ◽  
Verena Panitz ◽  
...  

Mass spectrometry imaging (MSI) vows to enable simultaneous spatially-resolved investigation of hundreds of metabolites in tissue sections, but it still relies on poorly defined ion images for data interpretation. Here, we outline moleculaR, a computational framework (https://github.com/CeMOS-Mannheim/moleculaR) that introduces probabilistic mapping and point-for-point statistical testing of metabolites in tissue. It enables collective molecular projections and consequently spatially-resolved investigation of ion milieus, lipid pathways or user-defined biomolecular ensembles within the same image.

2021 ◽  
Author(s):  
Denis Abu Sammour ◽  
James Cairns ◽  
Tobias Boskamp ◽  
Tobias Kessler ◽  
Carina Ramallo Guevara ◽  
...  

Abstract Mass spectrometry imaging (MSI) vows to enable simultaneous spatially-resolved investigation of hundreds of metabolites in tissue sections, but it still relies on poorly defined ion images for data interpretation. Here, we outline moleculaR, a computational framework in R, that introduces systematic probabilistic mapping and point-for-point statistical testing of metabolites in tissue to MSI. Beyond statistics, moleculaR allows for arithmetic operations within the same MS image and thereby, for instance, analysis and visualization of complex scores like the adenylate energy charge ([ATP]+0.5*[ADP])/ ([ATP]+[ADP]+[AMP]). moleculaR also enables collective molecular projections, for example of all potassium versus all sodium adducts for spatially-resolved investigation of ion milieus, or for surveys of lipid pathways or other user-defined biomolecular ensembles.


2021 ◽  
Vol 93 (5) ◽  
pp. 2767-2775
Author(s):  
Andreas Dannhorn ◽  
Stephanie Ling ◽  
Steven Powell ◽  
Eileen McCall ◽  
Gareth Maglennon ◽  
...  

2015 ◽  
Vol 21 (2) ◽  
pp. 187-193 ◽  
Author(s):  
Richard J. A. Goodwin ◽  
Anna Nilsson ◽  
C. Logan Mackay ◽  
John G. Swales ◽  
Maria K. Johansson ◽  
...  

Mass spectrometry imaging (MSI) provides pharmaceutical researchers with a suite of technologies to screen and assess compound distributions and relative abundances directly from tissue sections and offer insight into drug discovery–applicable queries such as blood-brain barrier access, tumor penetration/retention, and compound toxicity related to drug retention in specific organs/cell types. Label-free MSI offers advantages over label-based assays, such as quantitative whole-body autoradiography (QWBA), in the ability to simultaneously differentiate and monitor both drug and drug metabolites. Such discrimination is not possible by label-based assays if a drug metabolite still contains the radiolabel. Here, we present data exemplifying the advantages of MSI analysis. Data of the distribution of AZD2820, a therapeutic cyclic peptide, are related to corresponding QWBA data. Distribution of AZD2820 and two metabolites is achieved by MSI, which [14C]AZD2820 QWBA fails to differentiate. Furthermore, the high mass-resolving power of Fourier transform ion cyclotron resonance MS is used to separate closely associated ions.


Bioanalysis ◽  
2010 ◽  
Vol 2 (2) ◽  
pp. 279-293 ◽  
Author(s):  
Richard JA Goodwin ◽  
Andrew R Pitt

Sign in / Sign up

Export Citation Format

Share Document